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Abstract
 
The interaction of L-selectin expressed on lymphocytes with sulfated sialomucin ligands such as
CD34 and GlyCAM-1 on high endothelial venules (HEV) of lymph nodes results in lympho-
cyte rolling and is essential for lymphocyte recruitment. HEC-GlcNAc6ST–deficient mice lack
an HEV-restricted sulfotransferase with selectivity for the C-6 position of N-acetylglucosamine
 
(GlcNAc). HEC-GlcNAc6ST
 
 
 
/
 
 
 
 animals exhibit faster lymphocyte rolling and reduced lympho-
cyte sticking in HEV, accounting for the diminished lymphocyte homing. Isolated CD34 and
GlyCAM-1 from HEC-GlcNAc6ST
 
 
 
/
 
 
 
 animals incorporate 
 
 
 
70% less sulfate than ligands
from wild-type animals. Furthermore, these ligands exhibit a comparable reduction of the
epitope recognized by MECA79, a function-blocking antibody that reacts with L-selectin
ligands in a GlcNAc-6-sulfate–dependent manner. Whereas MECA79 dramatically inhibits
lymphocyte rolling and homing to lymph nodes in wild-type mice, it has no effect on HEC-
GlcNAc6ST
 
 
 
/
 
 
 
 mice. In contrast, in vitro rolling on purified GlyCAM-1 from HEC-
GlcNAc6ST
 
 
 
/
 
 
 
 mice, although greatly diminished compared with that on the wild-type
ligand, is inhibited by MECA79. Our results demonstrate that HEC-GlcNAc6ST contributes
predominantly, but not exclusively, to the sulfation of HEV ligands for L-selectin and that
alternative, non-MECA79–reactive ligands are present in the absence of HEC-GlcNAc6ST.
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Introduction
 
Lymphocyte rolling, the first step of lymphocyte recruitment
to lymph nodes, is mediated by the interaction of L-selectin
expressed on lymphocytes with glycoprotein ligands ex-
pressed by high endothelial cells (HEC). Rolling is essential
for subsequent lymphocyte activation through G-protein–
coupled receptors, firm adherence of the lymphocyte, and
its transmigration into the underlying lymph node paren-
chyma (for review see 1, 2).
All known L-selectin ligands expressed in mouse peripheral
lymph nodes are reactive with the function-blocking
monoclonal antibody MECA79 and are collectively called
peripheral lymph node addressin (PNAd) (3). In human
tonsils, CD34, podocalyxin, and endomucin, in addition to
other molecularly unidentified ligands, comprise the PNAd
complex (4–6). In the mouse, four HEV-expressed proteins
that carry the MECA79 epitope have been identified:
GlyCAM-1, CD34, Sgp200, and endomucin (6, for review
see 7). These glycoprotein ligands are all sialomucins (7).
CD34 is a transmembrane protein (8), whereas GlyCAM-1
is a peripheral membrane protein found both associated
with HEC and as a secreted molecule in serum (9).
 
L-selectin functions as a C-type lectin, its binding being
critically dependent on the appropriate posttranslational
modification of its endothelial ligands (7). As detailed below,
L-selectin recognizes sialyl Lewis X (sLex) modified with
GlcNAc-6-sulfate (6-sulfo-sLex). The importance of sialyla-
tion of the ligands has been demonstrated both in vitro and
in vivo (10, 11). The critical participation of fucosylation
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Abbreviations used in this paper:
 
 FucT, fucosyltransferase; GlcNAc, 
 
N
 
-ace-
tylglucosamine; HEC, high endothelial cell; HEC-GlcNAc6ST, HEC-
GlcNAc-6-sulfotransferase; HEV, high endothelial venule; LSST, L-selec-
 
tin ligand sulfotransferase; OSGE, O-sialoglycoprotein endopeptidase;
PNAd, peripheral node addressin; sLex, sialyl Lewis X.T
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in lymphocyte homing has been established through the
analysis of mice deficient in two 
 
 
 
1,3-fucosyltransferases,
FucT-IV and FucT-VII (12). The contribution of sulfation
was first demonstrated using chlorate, a metabolic inhibitor
of sulfation (13, 14). Biochemical analysis of mouse Gly-
CAM-1 and CD34 revealed that GlcNAc-6-SO
 
4
 
 com-
prises at least 50% (15, unpublished data) of the sulfated
saccharides, whereas it makes up 
 
 
 
90% of the sulfated sac-
charides within human tonsilar ligands (16). A structural
analysis first revealed that 6-sulfo-sLex (sialyl Lewis x mod-
ified with GlcNAc-6-SO
 
4
 
) to be a major capping group of
the O-linked chains of GlyCAM-1 (17), a finding that was
confirmed in human with a panel of mAbs (18).
These results stimulated interest in the GlcNAc-6-O-
sulfotransferase responsible for the L-selectin ligand modifi-
cation. One enzyme discovered through these efforts has
an expression pattern highly restricted to HEV. Indepen-
dently cloned by two groups, this enzyme is known alter-
natively as HEC-GlcNAc6ST (19) or L-selectin ligand sul-
fotransferase (LSST) (20). In reconstitution experiments,
GlyCAM-1-IgG coexpressed with HEC-GlcNAC6ST and
FucT-VII supports greater rolling of L-selectin
 
 
 
 cells than
GlyCAM-1-IgG expressed with FucT-VII alone (21). Sim-
ilar results were obtained with CD34 (20).
The MECA79 antibody has proven a useful tool in the
elucidation of the mechanisms of lymphocyte rolling and re-
cruitment. It was originally identified based on its ability to
inhibit the L-selectin mediated attachment of lymphocytes
to HEV in lymph node sections as well as the homing of
lymphocytes to peripheral lymph nodes (3). Subsequent
intravital microscopy studies established that MECA79
potently blocks the initial tethering and rolling of lympho-
cytes in peripheral lymph node HEV (22). Biochemically,
MECA79 cross-reacts in a function-blocking manner with
the same complex of mucins (PNAd) recognized by L-selec-
tin (14, 23). The MECA79 epitope requires GlcNAc-6–sul-
fate in the context of an extended Core1 structure (24, 25).
To determine the role of HEC-GlcNAc6ST in vivo, we
have generated mice deficient in the enzyme (26). Our ini-
tial characterization showed that the in vitro binding of
lymphocytes to lymph node HEV and luminal staining of
HEV by an L-selectin chimera are eliminated in the null
mice (26). Additionally, MECA79 reactivity of HEV is
greatly diminished, with the residual staining being most
apparent on the abluminal aspect of these venules. In a
short-term assay, the ability of lymphocytes to home to
lymph nodes in vivo in HEC-GlcNAc6ST
 
 
 
/
 
 
 
 mice is
50% of that in wild-type mice. The residual homing in null
mice is entirely L-selectin dependent. Given the observed
decrease in luminal MECA79 reactivity, yet the retention
of L-selectin dependent homing, we proposed two classes
of luminal ligands for L-selectin. In wild-type mice, lym-
phocyte rolling is dependent on relatively high affinity,
MECA79-reactive ligands that we have termed class 1
ligands. We proposed that in null mice rolling is supported
by a MECA79-unreactive class 2 ligand. This class 2 ligand
is presumably of lower affinity or lower abundance than
class 1, since it does not stain with an L-selectin–IgM chi-
 
mera. The question of whether the class 2 ligand is simply
undersulfated class 1 ligands or a qualitatively distinct ligand
remained unanswered in our previous study.
To further our understanding of the contribution of
HEC-GlcNAc6ST to lymphocyte homing, we have un-
dertaken a detailed study of lymphocyte rolling in vivo as
well as a biochemical and biophysical characterization of
L-selectin ligands produced by HEC-GlcNAc6ST null mice.
 
Materials and Methods
 
Intravascular Staining with MECA79.
 
The MECA79 reactivity
of the luminal aspect of HEV was assessed by injecting 50 
 
 
 
g of
MECA79 (rat IgM) in 100 
 
 
 
l of PBS into tail veins of HEC-
GlcNAc6ST
 
 
 
/
 
 
 
 and 
 
 
 
/
 
 
 
 mice. After 30 min mice were killed
and PN dissected out. PN were snap-frozen in OCT and cryostat
sections were stained with 1.5 
 
 
 
g/ml Cy3-conjugated goat 
 
 
 
-rat
IgM (Jackson ImmunoResearch Laboratories) and processed for
immunofluorescence.
 
In Vivo Homing.
 
Lymphocyte homing in vivo was per-
formed according to published procedures (26). Briefly, HEC-
GlcNAc6ST
 
 
 
/
 
 
 
 and 
 
 
 
/
 
 
 
 mice were pretreated with 75 
 
 
 
g of
mAb MECA79 or PBS injected into tail veins. 1 h later, mouse
MN lymphocytes (1.7 
 
 
 
 10
 
7
 
) labeled with 5 mM 5-chloro-
methylfluorescein diacetate (CMFDA, Cell-Tracker; Molecular
Probes) were injected. 1 h after cells were injected, recipient mice
were killed, and PN (auxiliary and brachial nodes) were dissected
out. Fractional content of fluorescent cells was determined by
flow cytometry (FACScan, Becton Dickinson) (500,000 cells per
organ). To assess the effect of MECA79 on homing, the data
were normalized for each animal (fractional value of CMFDA
positive cells divided by the mean of the fractional values for all of
the PBS-injected mice of the same genotype within the experi-
ment). Data from two separate experiments were pooled, with a
total of five (
 
 
 
/
 
 
 
) or nine (
 
 
 
/
 
 
 
) animals per group.
 
Intravital Microscopy.
 
Intravital microscopy of the murine in-
guinal peripheral lymph node was performed as described (22,
27). Briefly, young adult (6–12 wk) HEC-GlcNAc6ST
 
 
 
/
 
 
 
 or
 
 
 
/
 
 
 
 controls were anesthetized by intraperitoneal injection of
10 ml/kg of saline containing xylazine (1 mg/ml) and ketamine
(5 mg/ml). A skin incision was made to expose the inguinal
lymph node. Calcein-labeled lymphocytes injected into a right
femoral artery catheter were visualized in LN microvasculature
by intravital epifluorescence microscopy (IV-500; Micron Instru-
ments) with a video-triggered xenon arc stroboscope (Chadwick-
Helmuth) and recorded on a Hi8 VCR (Sony). Offline video
analysis was performed as described previously (28). Rolling frac-
tion is measured as the percent of fluorescent cells interacting
with the vessel wall relative to the total number of fluorescent
cells passing through the vessel during the observation period.
The sticking fraction is defined as the percent of rolling fluores-
cent cells that arrest on the vessel wall for 
 
 
 
30 s. Velocity analysis
was performed using PC software capable of random line-length
measurements (29). The velocity of 
 
 
 
10 rolling and 20 noninter-
acting cells were measured for each venule to obtain mean fast
cell velocity (V
 
fast
 
), blood flow velocity (V
 
blood
 
), and rolling veloc-
ity (V
 
roll
 
) as described previously (28). To correct for the effect of
varying V
 
blood
 
 on V
 
roll
 
, we calculated the relative rolling velocity
(V
 
rel
 
) according to the formula V
 
rel
 
 
 
 
 
 V
 
roll
 
/V
 
blood
 
 
 
 
 
 100%.
All data are shown as mean 
 
 
 
 SEM, unless otherwise noted.
Rolling and sticking fractions were compared using an unpaired
Student’s 
 
t
 
 test. Statistical analysis of velocity histograms was per-T
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formed using the Mann-Whitney test and the Kolmogorov-
Smirnov test. Differences were considered statistically significant
when P 
 
  
 
0.05.
 
Isolation and Analysis of Sulfated Ligands.
 
Equal masses of
mesenteric and PN were harvested from HEC-GlcNAC6ST
 
 
 
/
 
 
 
and 
 
 
 
/
 
 
 
 mice and minced. About 0.5 g of LN tissue was incu-
bated in 2 ml of sulfate-free RPMI 1640 supplemented with
HEPES buffer, penicillin/streptomycin, and 2 mCi Na
 
35
 
SO
 
4
 
(ICN) overnight in a cell-culture incubator. GlyCAM-1 was iso-
lated by immunoprecipitation from the conditioned medium
with 20 
 
 
 
g CAMO2 (antipeptide 2 polyclonal Ab) (30). CD34
was isolated by immunoprecipitation from clarified precleared ly-
sates of tissue pieces with 10 
 
 
 
g RAM34 mAb (PharMingen).
Immunoprecipitates were quantified by Western blotting with
CAMO5 (antipeptide 5 polyclonal Ab) (30) or a polyclonal anti-
body directed to murine CD34 (31). MECA79 reactivity was
quantified by Western blotting and densitometry. Sulfate incor-
poration was determined by autoradiography and densitometry.
 
Purification of GlyCAM-1 from Serum.
 
GlyCAM-1 was puri-
fied from serum essentially as described (32). Briefly, 20 ml of se-
 
rum from HEC-GlcNAC6ST
 
 
 
/
 
 
 
 or 
 
 
 
/
 
 
 
 mice was extracted
with chloroform:methanol (4:1), dialyzed overnight against PBS,
clarified by centrifugation, and precleared with protein A before
precipitation with CAMO2 bound to protein A. GlyCAM-1 was
recovered by incubating beads with 1 mg/ml CAMO2 peptide,
separated from eluting peptide by extensive washing, and con-
centrated using Centricon-30 filter concentrators (Amicon).
 
ELISAs.
 
To equalize coating densities of serum-derived Gly-
CAM-1, ELISAs were performed. Protein was coated onto 96-well
Immulon-2 plates (Dynex Labs) and detected with biotinylated
anti-GlyCAM-1 peptide Ab (5) (30) followed by streptavidin-
conjugated alkaline phosphatase. MECA79 reactivity was deter-
mined using biotinylated MECA79 (Ligocyte Pharmaceuticals).
L-selectin–IgM was prepared as described by Bistrup (19). E-selec-
tin–IgM and P-selectin-IgM chimeras, produced according to
published procedures (33), were provided by Dr. Lloyd Stoolman.
Fucosylation was detected using 
 
Aleuria aurantia
 
 lectin (AAL-bio-
tin, Vector) with inhibition by 50 mM fucose (Sigma-Aldrich).
 
Flow Chamber Analysis.
 
For these experiments, polystyrene
dishes coated with serum-derived GlyCAM-1 in Tris-buffered
Figure 1. Intravascular stain-
ing with MECA79 and effect on
in vivo homing. (A–D)
MECA79 mAb was injected
intravenously  into HEC-
GlcNAc6ST /  or  /  mice.
30 min later peripheral lymph
nodes were dissected out and
processed for immunofluorescence
microscopy. Bright field images
of  /  (A) and  /  (C) lymph
nodes. Intravascular staining with
MECA79 of (B)  /  and (D)
 /  HEV. Magnification
200 . (E) MECA79 mAb or
PBS was injected intravenously
into HEC-GlcNAc6ST /  or
 /  mice and the homing of
fluorescently labeled cells was
determined and normalized to
produce a homing index as de-
scribed in Materials and Methods.
Consistent with our previous
findings (26), homing in the
HEC-GlcNAc6ST /  mice
was 59% relative to homing in
wild-type.T
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saline, pH 9, overnight at 4
 
 
 
C. Blocked dishes were incorpo-
rated as the lower wall of a parallel plate flow chamber (34). Hu-
man Jurkat T cells or 38C13 murine lymphoma cells were per-
fused through the flow chamber at 1–2 
 
 
 
 10
 
6
 
 cells/ml. The
number of rolling cells and rolling velocity was determined as
described in (34). For inhibition studies, cells were pretreated
with 5 
 
 
 
g/ml DREG56 (Caltag) or resuspended in Ca
 
2
 
 
 
/Mg
 
2
 
 
 
-
free HBSS with 5mM EDTA. For sialidase inhibition, coated
substrates were treated with 10 mU/ml 
 
Vibrio cholera
 
 sialidase
(Glyko) for 30 min at RT. For MECA79 inhibition experi-
ments, coated substrates were incubated with MECA79 after the
usual blocking step.
 
Results
 
Intravascular Staining with MECA79.
 
We had previ-
ously observed by conventional staining of sections that
HEV of HEC-GlcNAc6ST null mice have reduced lumi-
nal MECA79 reactivity (26). To directly assess the presence
of epitopes accessible to the blood, we injected MECA79
intravenously into HEC-GlcNAc6ST
 
 
 
/  and  / 
mice. Animals were killed 30 min later. Cryostat sections of
peripheral lymph nodes were stained for the presence of
bound primary antibody. Whereas MECA79 staining was
strongly associated with HEV of wild-type mice, it was
very weak or undetectable on the luminal surface of HEV
in HEC-GlcNAc6ST /  mice (Fig. 1 D).
MECA79 Inhibition of Homing in HEC-GlcNAc6ST Null
Mice. Streeter et al. (3) first reported the ability of
MECA79 to inhibit homing to peripheral lymph nodes in
mice. MECA79 has also been shown to substantially
( 90%) inhibit L-selectin–dependent rolling in HEV by
intravital microscopy (22). Since we had observed that
HEC-GlcNAc6ST null mice had greatly reduced luminal
MECA79 reactivity (Fig. 1 D), we wanted to determine
whether MECA79 would inhibit homing of lymphocytes
in these animals. We investigated this question by injecting
mice with MECA79 mAb intravenously 1 h before the in-
jection of fluorescently labeled lymphocytes. Lymphocyte
homing was quantified by flow cytometry, which allowed
the enumeration of the percentage of fluorescently labeled
cells normalized to the total number of cells in peripheral
lymph nodes. Strikingly, MECA79 had no effect on hom-
ing to lymph nodes in HEC-GlcNAc6ST null animals,
while homing in wild-type animals was almost completely
inhibited (Fig. 1 E). Since the residual homing to lymph
nodes in the null mice is completely dependent on L-selec-
tin (26), these results establish that in the absence of
HEC-GlcNAc6ST, L-selectin can function in lymphocyte
homing to peripheral nodes independently of MECA79-
reactive ligands.
Intravital Microscopy of Peripheral Lymph Nodes of HEC-
GlcNAc6ST Null Mice. To directly observe the effect of
deletion of HEC-GlcNAc6ST on the interaction of lym-
phocytes with HEV in vivo, we employed intravital mi-
croscopy. Von Andrian has described the hierarchical
branching of venules within peripheral lymph nodes and
defined five distinct venular orders with orders 3–5 corre-
sponding to paracortical HEV (22). As shown in Fig. 2 A,
the rolling fraction of lymphocytes was not significantly
different between HEC-GlcNAc6ST /  and wild-type
mice. However, the sticking fraction of lymphocytes was
significantly diminished in null mice (Fig. 2 B). While the
sticking fraction was comparable in third order venules of
wild-type and null mice, it was reduced to 27% (P  
0.0001) and 19% of wild-type (P   0.005) in fourth and
fifth order venules, respectively. Since the majority ( 90%)
of lymphocyte accumulation occurs in fourth and fifth or-
der HEV (27), the observed defect in lymphocyte sticking
was consistent with the observed 50% decrease in lympho-
cyte homing in HEC-GlcNAc6ST null mice (26).
The median velocity of lymphocyte rolling in third or-
der venules was 43  m/s in wild-type mice and increased
to 58  m/s in null mice (P   0.5, Fig. 3 A). The difference
in fourth order venules was much more dramatic, with a
greater than fourfold increase from 21  m/s in wild-type
mice to 89  m/s in null mice (P   0.0001) (Fig. 3 C).
These differences could not be explained by hemodynamic
factors, since the frequency distribution of rolling velocities
normalized to the mean blood flow velocity in each venule
(Vrel) was shifted in third order (Fig. 3 B) and, especially,
fourth order venules (P   0.0001, Fig. 3 D). Velocities
were not measured in fifth order venules, since the accu-
mulation of adherent cells obscured many venule segments.
Our data represent the first reported case where the veloc-
ity of lymphocyte rolling in peripheral lymph node HEV
has been perturbed.
Figure 2. Lymphocyte rolling
and sticking fractions in HEV of
HEC-GlcNAc6ST /  mice.
(A) Rolling fractions were deter-
mined as the percentage of rolling
cells in the total flux of fluores-
cently labeled lymphocytes. Data
are based on four HEC-
GlcNAc6ST /  mice (1st-4;
2nd-5; 3rd-7; 4th-16; 5th-11
venules) and four  /  mice
(1st-2; 2nd-9; 3rd-12; 4th-16;
5th-7 venules). Bars represent
mean   SEM. (B) Sticking frac-
tions were determined as the percentage of rolling cells that subsequently arrested (stationary  30 s). Data are based on the same four HEC-GlcNAc6ST / 
and four  /  mice and venules indicated in A. Sticking was not observed in first order venules or in second order venules in  /  mice.T
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Since we observed that MECA79 had no effect on the
ability of lymphocytes to home to lymph nodes in HEC-
GlcNAc6ST null mice (Fig. 1), we expected that lym-
phocyte rolling in peripheral lymph node HEV would be
insensitive to MECA79. To test this hypothesis, we in-
jected mice with either MECA79 or a control rat IgM 15
min before the injection of fluorescently labeled lympho-
cytes. MECA79 treatment nearly eliminated rolling in
wild-type mice (76–94% inhibition in second to fifth or-
der venules), while the rolling fraction in MECA79
treated HEC-GlcNAc6ST /  mice was unchanged
(Fig. 4 A). The isotype control antibody did not affect the
rolling fraction (Fig. 4 A) or sticking fraction (not de-
picted) in either HEC-GlcNAc6ST /  or  /  mice.
To confirm that MECA79-resistant rolling in the null
mice remained L-selectin dependent (26), we employed
lymphocytes isolated from L-selectin null animals. When
these cells were injected into HEC-GlcNAc6ST / 
mice that had been pretreated with MECA79, no rolling
was observed (Fig. 4 B).
Figure 3. Lymphocyte rolling velocities
in HEC-GlcNAc6ST /  mice. (A and C)
Cumulative rolling velocity curves for third
order (A) and fourth order (C) venules. The
percentage of cells that rolled at or below a
given velocity is shown as a function of
Vroll. n   cells/venules/mice. (B and D)
Distribution of Vrel frequencies for third order
(B) and fourth order (D) venules. Vrel was
calculated as described in Materials and
Methods and cells were assigned to Vrel
classes ranging from  0 to  2%, 2% to
 4%, and so on.
Figure 4. Effect of MECA79
mAb on lymphocyte rolling. (A)
MECA79 mAb or isotype control
rat IgM was injected via a femoral
artery catheter into HEC-
GlcNAc6ST /  or  /  mice.
15 min later, fluorescently labeled
lymphocytes were injected.
Data are based on 2 HEC-
GlcNAc6ST /  mice injected
with rat IgM (1st-2; 2nd-5; 3rd-8;
4th-5; 5th-2 venules), two  / 
mice injected with rat IgM (1st-1;
2nd-2; 3rd-3; 4th-3; 5th-3
venules), two HEC-GlcNAc6ST /  mice injected with MECA79 (1st-3; 2nd-6; 3rd-8; 4th-8; 5th-7 venules), and 2  /  mice injected with
MECA79 (1st-2; 2nd-5; 3rd-8; 4th-8; 5th-5 venules). Bars represent mean   SEM. (B) Fluorescently labeled L-selectin /  lymphocytes were injected
into HEC-GlcNAc6ST /  mice treated with MECA79. Data are based on 4 HEC-GlcNAc6ST /  mice injected with MECA79 (1st-3; 2nd-6;
3rd-8; 4th-9; 5th-7 venules) and one HEC-GlcNAc6ST /  mouse injected with MECA79 and L-selectin /  lymphocytes (1st-1; 2nd-3; 3rd-5;
4th-3; 5th-2 venules).T
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Sulfate Incorporation into L-Selectin Ligands in HEC-
GlcNAc6ST Null Mice. We had previously observed that
staining of lymph node HEV by an L-selectin chimera or
MECA79 was greatly diminished in HEC-GlcNAc6ST / 
animals (26), consistent with the sulfation dependency
of these interactions. We wanted to confirm this associa-
tion by investigating the effect of the genetic deletion of
HEC-GlcNAc6ST on the degree of sulfate incorporation
into isolated L-selectin ligands. 35SO4-GlyCAM-1 and
-CD34 were, respectively, immunoprecipitated from con-
ditioned media and detergent lysates of metabolically la-
beled lymph nodes. The bands were quantified for protein
by Western blotting and for sulfate incorporation by auto-
radiography (Fig. 5). When normalized for protein, Gly-
CAM-1 from HEC-GlcNAc6ST /  lymph nodes in-
corporated 37.3    2.7% of the 35SO4 compared with
GlyCAM-1 from wild-type mice (Fig. 5 B). Additionally,
there was an increase in the SDS-PAGE mobility of HEC-
GlcNAc6ST /  GlyCAM-1 compared with wild-type
GlyCAM-1, consistent with the previous observations ob-
tained with undersulfated GlyCAM-1 (13). CD34 from
HEC-GlcNAc6ST /  mice incorporated 33.8   2.5% of
the 35SO4 label compared with wild-type CD34 (Fig. 5 E).
These results establish that HEC-GlcNAc6ST is the domi-
nant (but not the exclusive) enzyme contributing to the
sulfation of both CD34 and GlyCAM-1, two major com-
ponents of mouse PNAd.
MECA79 Reactivity of L-Selectin Ligands in HEC-
GlcNAc6ST Null Mice. To quantify the level of the
MECA79 epitope expressed on L-selectin ligands, Gly-
CAM-1 and CD34 were immunoprecipitated from lymph
nodes of wild-type and HEC-GlcNAc6ST /  mice with
protein-specific antibodies against these components. Pro-
teins were quantified and the MECA79 reactivity was de-
termined by Western blotting. The normalized MECA79
reactivity of GlyCAM-1 derived from null lymph nodes
was 29.9   10.8% of that found on wild-type GlyCAM-1
(Fig. 5 C). Similarly, CD34 from null mice showed 25.9  
11.5% of the normalized MECA79 reactivity compared
with wild-type CD34 (Fig. 5 F). Fig. 5 G summarizes the
relative sulfate incorporation and MECA79 reactivity of
lymph node derived GlyCAM-1 and CD34.
In a parallel analysis, we also analyzed GlyCAM-1 from
serum. With equal quantities of coated GlyCAM-1 (Fig. 6
A), the relative MECA79 reactivity of serum GlyCAM-1
from HEC-GlcNAc6ST /  mice was 28.5   2.8% of
that from wild-type mice (Fig. 6 B). This result demon-
strated that the normalized MECA79 reactivity of serum
GlyCAM-1 paralleled the reactivity of GlyCAM-1 and
CD34 purified from lymph nodes. Serum GlyCAM-1 is
abundant and easily purified (32) and thus provided us the
means to investigate the biochemical and biophysical
properties of a PNAd component formed in situ in the
presence or absence of HEC-GlcNAc6ST. In an analo-
gous approach, Homeister et al. (12) took advantage of se-
rum GlyCAM-1 to study the contributions of FucT-IV
and FucT-VII in the elaboration of lymph node ligands for
L-selectin.
Interaction of GlyCAM-1 from HEC-GlcNAc6ST Null
Mice with L-, P-, and E-Selectin. Using an L-selectin–IgM
chimera as a histochemical probe, we previously observed
that the lack of HEC-GlcNAc6ST results in the complete
loss of luminal staining from lymph node HEV (26). To
examine the selectin binding activities of isolated ligands,
we purified GlyCAM-1 from the sera of HEC-
GlcNAc6ST /  and wild-type mice, coated equivalent
levels of the proteins on ELISA plates, and performed bind-
ing assays with the L-selectin–IgM chimera. Wild-type–
derived GlyCAM-1 demonstrated significant L-selectin re-
activity over a range of chimera concentrations (Fig. 6 C),
whereas GlyCAM-1 from HEC-GlcNAc6ST /  mice
was completely unreactive at all chimera concentrations.
Figure 5. 35Sulfate incorporation and MECA79 reactivity of GlyCAM-1
and CD34. (A and D) Lymph nodes from HEC-GlcNAc6ST /  and
 /  mice were incubated with Na35SO4. Immunoprecipitated GlyCAM-1
and CD34 were separated by SDS-PAGE and transferred to PVDF for
Western blotting. (A) GlyCAM-1 was detected with an antipeptide Ab
(CAMO5). (D) CD34 was detected with an affinity-purified polyclonal
Ab. (B and E) 35S-labeled immunoprecipitated ligands GlyCAM-1 (B)
and CD34 (E) detected by autoradiography. (C and F) MECA79 reactivity of
GlyCAM-1 (C) and CD34 (F) detected by Western blotting. (G) Relative
sulfate incorporation and MECA79 reactivity of GlyCAM-1 and CD34
from HEC-GlcNAc6ST /  mice. 35S incorporation was measured by
performing densitometry on autoradiographs as shown in B and E and
normalized for protein based on Western blots performed in parallel with
protein-specific Abs as in A and D. MECA79 reactivity was measured by
performing densitometry on Western blots shown in C and F and normalized
based on protein-specific Western blots performed in parallel. Data are
the means   SEMs of three independent preparations.T
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The binding of P-selectin–IgM to GlyCAM-1 from null
mice was also significantly diminished compared with its
binding to wild-type GlyCAM-1 (Fig. 6 D). We also tested
E-selectin, whose binding to ligands is dependent on both
sialic acid and fucose but independent of sulfation (21). As
shown in Fig. 6 E, E-selectin–IgM bound equivalently to
GlyCAM-1 from  /  and  /  mice (Fig. 6 E). Simi-
larly, a lectin from Aleuria aurantia (AAL) that preferentially
binds  1,3-linked fucose bound equivalently to the two
forms of GlyCAM-1 (Fig. 6 F).
Lymphocyte Rolling on GlyCAM-1 from HEC-GlcNAc6ST
Null Mice. To augment our biochemical analysis, we in-
vestigated the biophysical characteristics of isolated ligands
in a parallel plate flow chamber. The flow chamber pro-
vides a means to determine parameters of rolling interac-
tions under physiologic conditions of shear stress. We
coated equal amounts of GlyCAM-1 purified from the sera
of HEC-GlcNAc6ST /  and  /  mice onto plates and
assessed their ability to support rolling of human L-selec-
tin–expressing Jurkat T cells. Although rolling on Gly-
CAM-1 from HEC-GlcNAc6ST /  mice was observed,
significantly fewer cells rolled stably over a range of shear
stresses as compared with rolling on wild-type protein (Fig.
7 A). GlyCAM-1 from null mice also exhibited a marked
decrease in the strength of rolling adhesion, with no inter-
action evident at shear stresses  8 dyn/cm2. Rolling on ei-
ther form of GlyCAM-1 was confirmed to be L-selectin
dependent, as it was completely inhibited by the addition
of EDTA or the function-blocking monoclonal antibody
DREG56 (Fig. 7, legend). Treatment of either form of
coated GlyCAM-1 with sialidase also completely inhibited
rolling, confirming that the L-selectin interaction was sialic
acid dependent (Fig. 7, legend). Rolling was substantially
faster on GlyCAM-1 from HEC-GlcNAc6ST /  (1.6-
fold higher at a shear stress of 1 dyn/cm2) (Fig. 7 B).
Given that MECA79 had no effect on lymphocyte roll-
ing in HEV of HEC-GlcNAc6ST /  mice in vivo, we
wanted to determine if GlyCAM-1 purified from HEC-
GlcNAc6ST /  mice retained sensitivity to MECA79
inhibition. In striking contrast to the complete lack of ef-
fect in vivo, MECA79 strongly inhibited rolling on Gly-
CAM-1 purified from HEC-GlcNAc6ST /  mice with
 85% inhibition at 1  g/ml of MECA79 (Fig. 7 C).
Over a range of MECA79 concentrations (1–10 g/ml),
the degree of inhibition of HEC-GlcNAc6ST /  Gly-
CAM-1 was equivalent to that seen with wild-type Gly-
CAM-1. In a further experiment, 10  g/ml of MECA79
was applied to varying concentrations of coated HEC-
Figure 6. ELISA analyses of GlyCAM-1 from HEC-GlcNAc6ST /  mice. Equivalent amounts of HEC-GlcNAc6ST /  and  /  GlyCAM-1
were coated on ELISA plates. (A) Protein was quantified using an anti–GlyCAM-1 Ab. (B) Relative MECA79 reactivity. L-selectin–IgM (C), P-selectin–
IgM (D), or E-selectin–IgM (E) chimeric proteins or biotinylated-AAL (F) were allowed to bind and were subsequently detected with an alkaline phosphatase-
conjugated secondary Ab. EDTA (selectins) or fucose (AAL) was used to show specificity of the respective interactions. Plots are representative of three
experiments performed on two independent preparations of GlyCAM-1. T
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GlcNAc6ST /  and  /  GlyCAM-1 that supported
either high or low levels of rolling. Inhibition of rolling
was equivalent ( 90%) for both forms of GlyCAM-1 at
all concentrations tested (Fig. 7 D). A similar pattern of
inhibition with MECA79 was observed when 38C13
cells, a cell line expressing murine L-selectin, were used to
test rolling on HEC-GlcNAc6ST /  and  /  Gly-
CAM-1. Although a higher concentration of MECA79
was necessary to achieve inhibition with these cells,
equivalent inhibition was observed on both types of Gly-
CAM-1 (unpublished data).
Discussion
Our initial characterization of HEC-GlcNAc6ST / 
mice revealed a marked phenotype with decreased lym-
phocyte homing and reduced lymphocyte numbers in pe-
ripheral lymph nodes (26). The observation that the 50%
residual homing in these animals continues to be L-selectin
dependent prompted our investigation of the L-selectin
ligands that function in the absence of HEC-GlcNAc6ST.
To directly observe the effect of deletion of HEC-
GlcNAc6ST on the rolling of lymphocytes in peripheral
lymph node HEV, we employed intravital microscopy. We
found no difference in the lymphocyte rolling fraction be-
tween HEC-GlcNAc6ST /  and  /  mice, but a sub-
stantial defect in lymphocyte sticking in fourth and fifth or-
der venules of HEC-GlcNAc6ST /  mice. Measurement
of the velocity of rolling cells revealed a dramatic (fourfold)
increase in rolling velocity in fourth order venules. It is
plausible that this increase in rolling velocity in the null
mice explains the observed defect in lymphocyte sticking in
higher order venules; that is, the increase in rolling velocity
may decrease the efficiency of chemokine signaling by de-
creasing the time of exposure of rolling cells to endothelial-
associated chemokines. Analogously, when  4 7 integrin
function is blocked or genetically inactivated, the velocity of
lymphocyte rolling in HEV of Peyer’s patches increases dra-
matically and sticking is greatly reduced (35). Sulfated car-
bohydrates have been shown to bind chemokines, such as
CCL21 (36), whose presentation on the luminal surface of
HEV is essential to induce sticking of rolling T cells (37).
Thus, it is conceivable that undersulfation of molecules on
the luminal surface of HEV in HEC-GlcNAc6ST / 
mice may reduce the presentation of CCL21 in high order
venules, thus contributing to the observed defect in lym-
phocyte sticking. Undersulfation of ligands could also affect
sticking by diminishing outside-in signaling processes de-
pendent on L-selectin ligand engagement (38).
We have confirmed here that HEC-GlcNAc6ST / 
mice have dramatically reduced levels of luminal reactivity
for MECA79 in lymph node HEV. Consistent with this
observation, neither in vivo homing to peripheral lymph
nodes nor lymphocyte rolling on HEV was affected by ad-
ministration of MECA79 mAb to the null animals. Yet,
rolling of lymphocytes on HEV remained L-selectin de-
pendent. These observations provide a direct demonstra-
tion of the existence of one or more MECA79-unreactive
ligand(s) for L-selectin that function(s) in lymph node HEV
in the absence of HEC-GlcNAc6ST.
To investigate the L-selectin ligands present in HEC-
GlcNAc6ST /  mice, we focused on components of the
PNAd complex. We purified GlyCAM-1, a secreted pe-
ripheral membrane protein, and CD34, a type I transmem-
brane protein, from lymph nodes. CD34 has been shown
by EM immunocytochemical studies to be predominantly
on the luminal surface of blood vessels (8). GlyCAM-1 and
CD34 purified from lymph nodes were significantly under-
sulfated in HEC-GlcNAc6ST /  mice, incorporating
65% less sulfate on a per mass basis than the same ligands
Figure 7. Jurkat cell rolling on
GlyCAM-1. (A) Equivalent
amounts of HEC-
GlcNAc6ST /  and  / 
GlyCAM-1 were coated on
dishes. Jurkat cells were perfused
through the flow chamber and
the number of rolling cells was
determined for each shear stress.
Values represent the mean  
SD. Addition of EDTA, mAb
DREG56, or sialidase treatment
of   /  and  /  GlyCAM-1
inhibited  95% of rolling. The
experiment shown is representa-
tive of three independent experi-
ments each performed in duplicate
using two different fields of
view. (B) The velocity of 40
rolling cells was determined for
each shear stress. Values represent
the mean   SD. (C) GlyCAM-1
from HEC-GlcNAc6ST / 
and  /  mice was coated such
that nearly equivalent numbers
of rolling cells were observed at
wall shear stress of 1–2 dyn/cm2.
Dishes were treated with varying
concentrations of MECA79
mAb and rolling of Jurkat T cells
was determined. Data was nor-
malized based on the number of
cells that rolled in the absence of
mAb. Data shown is for a shear
stress of 1 dyn/cm2. (D) Varying
concentrations of GlyCAM-1
from HEC-GlcNAc6ST / 
and   /  mice were coated
yielding two different levels of
rolling for each form of Gly-
CAM-1. The effect of 10  g/ml
of MECA79 on rolling was deter-
mined for each type and concen-
tration of GlyCAM-1. Values
represent the mean   SD for
shear stress of 1 dyn/cm2.T
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purified from wild-type mice. Consistent with the direct
sulfation measurements, a similar decrease was seen in the
reactivity of these ligands with the sulfation-dependent an-
tibody MECA79. Analysis of acid hydrolysates of Gly-
CAM-1 from HEC-GlcNAc6ST /  mice indicated that
GlcNAc-6–SO4 was the predominant ( 75% of the total)
sulfated saccharide present (unpublished data). Further-
more, the ligand activity of HEC-GlcNAc6ST /  Gly-
CAM-1 was blocked by MECA79, which requires
GlcNAc-6–SO4 for binding (25). Therefore, we conclude
that the residual ligand activity of GlyCAM-1 is dependent
on the GlcNAc-6–SO4 modification rather than other sul-
fation modifications.
We wanted to confirm that the defect in HEC-
GlcNAc6ST /  mice was restricted to sulfation and did
not secondarily affect sialylation or fucosylation of ligands.
The E-selectin–IgM binding results demonstrated that the
sLex moiety was present to equivalent levels on Gly–
CAM-1 from both types of mice. Equivalent binding by
the fucose-specific lectin AAL was further evidence that fu-
cosylation of GlyCAM-1 was not perturbed in HEC-
GlcNAc6ST /  mice. In contrast, GlyCAM-1 from
HEC-GlcNAc6ST /  mice was unable to support bind-
ing of L-selectin–IgM and was also defective in P-selectin–
IgM binding. These results demonstrated that this Gly-
CAM-1 was selectively deficient in the sulfate modification
critical for L-selectin and, to a lesser degree, P-selectin
binding. P-selectin on activated platelets has previously
been shown to recognize the posttranslational modifica-
tions of PNAd and to mediate platelet binding to HEV
(39). MECA79 treatment substantially reduced the interac-
tion of platelets with HEV, suggesting that the recognition
determinant for L- and P-selectin on PNAd are shared.
Our result demonstrated that P-selectin is less stringent
than L-selectin in its dependency on the GlcNAc-6–sulfate
modification generated by HEC-GlcNAc6ST.
Although GlyCAM-1 from HEC-GlcNAc6ST / 
mice was unable to bind L-selectin in a stringent equilib-
rium binding assay, we wanted to observe its activity in the
flow chamber, a more sensitive assay to determine pertur-
bations in the formation and dissociation of bonds between
L-selectin and its ligands. GlyCAM-1 from null animals
was able to support lymphocyte rolling, but significantly
fewer cells rolled over a range of shear stresses. Rolling ve-
locities were significantly increased and the strength of roll-
ing adhesions was greatly diminished. Since GlyCAM-1
from HEC-GlcNAc6ST /  mice appears to be modified
with sialic acid and fucose at levels equivalent to wild-type,
the observed increase in rolling velocity and decrease in
shear resistance in the flow chamber is most likely the con-
sequence of the defect in sulfation.
The presence of GlcNAc-6–SO4 and MECA79 reactiv-
ity on GlyCAM-1 and CD34 in the absence of HEC-
GlcNAc6ST indicates that a second HEV-expressed
GlcNAc-6–sulfotransferase modifies components of PNAd
and is capable of creating the MECA79 epitope. A strong
candidate for this enzyme is GlcNAc6ST which is ex-
pressed at the mRNA level within murine lymph node
HEC (40). This enzyme can participate in the generation
of both the 6-sulfo-sLex epitope (19, 24) and the MECA79
epitope (24) in transfected cells.
A decrease in the GlcNAc-6–sulfation of ligands like
GlyCAM-1 and CD34 could conceivably explain the in-
creased rolling velocity that we observed by intravital mi-
croscopy in higher order venules of HEC-GlcNAc6ST / 
lymph nodes. Indeed, we confirmed that undersulfated
GlyCAM-1 supports faster rolling in the flow chamber.
However, our MECA79 inhibition results argue that these
observations are not simply attributable to diminished sul-
fation of PNAd components. While MECA79 completely
inhibited in vitro rolling on null mice-derived GlyCAM-1
over a range of ligand concentrations, we observed no ef-
fect of this antibody on in vivo homing, rolling, or lym-
phocyte arrest in lymph nodes of the null mice. It is possi-
ble GlyCAM-1 from HEC-GlcNAc6ST null mice does
not accurately reflect the altered posttranslational modifi-
cations of CD34 and other integral membrane compo-
nents of PNAd and therefore is not an appropriate sur-
rogate of the PNAd-adhesive complex in these mice.
Countering this possibility, we observed the same reduc-
tions in overall sulfation and the expression of the
MECA79 epitope on both GlyCAM-1 and CD34 when
HEC-GlcNAc6ST was absent. Therefore, we believe that
the deficiency in the ligand activity of null mice-derived
GlyCAM-1, as well as its susceptibility to inhibition by
MECA79, applies to other members of the PNAd com-
plex. If this generalization is valid, then the contrasting ef-
ficacies of MECA79 in vivo and in vitro in the null mice
would argue for the existence of MECA79-unreactive
ligands that become functionally predominant in the ab-
sence of HEC-GlcNAc6ST. We proposed such ligand ac-
tivity and termed it “class 2” in our initial characterization
of HEC-GlcNAc6ST null animals (26). The present find-
ings indicate that the class 2 ligand is based on a novel pro-
tein scaffold with distinctive posttranslational modifica-
tions. Furthermore, since MECA79 treatment potently
inhibits rolling in wild-type lymph nodes and does not re-
capitulate the faster rolling we observed in HEC-
GlcNAc6ST /  mice, our results imply that the class 2
ligand is up-regulated in higher order venules of HEC-
GlcNAc6ST /  mice.
A MECA79-unreactive L-selectin ligand is expressed in
HEV of Peyer’s patches. This ligand supports fast rolling
and is essential to the homing of lymphocytes to this organ
(41, 35). Interestingly, the pattern of MECA79 staining of
HEC-GlcNAc6ST /  lymph nodes is reminiscent of that
seen in Peyer’s patches, a tissue in which HEC-
GlcNAc6ST is not expressed (19). MECA79 reactivity is
apparent only on the abluminal aspect of the HEV of wild-
type Peyer’s patches, consistent with the inability of
MECA79 to block homing to this organ (3). MAdCAM-1
is proposed to be the predominant L-selectin ligand in
HEV of Peyer’s patches, in addition to its function as a
counter receptor for  4 7 (35). However, we have not
observed an up-regulation of MAdCAM-1 expression in
lymph nodes of HEC-GlcNAc6ST /  mice (26).T
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Additional class 2 ligand candidates are those that support
rolling of lymphocytes on HEV of frozen sections of hu-
man tonsils following treatment of the sections with the
mucin degrading enzyme OSGE (42). This ligand is not
blocked by MECA79, although it has reactivity with sLex-
specific mAbs. Further evidence for diversity in ligands for
L-selectin in human lymphoid tissues comes from studies of
Michie et al. (43). These investigators found that MECA79
inhibits the adhesion of an L-selectin  lymphoma cell line
to HEV of human peripheral nodes by only 41%. The di-
versity of carbohydrate determinants on PNAd compo-
nents has been demonstrated using a panel of monoclonal
antibodies that differentially stain human lymphoid tissues
and variably cross-block MECA79 (44). Tu et al. (45) have
described a MECA79-unreactive, sulfate and sialic acid–
dependent L-selectin ligand which is expressed on human
endothelial cells in culture. In contrast, cytokine-activated
cardiac microvascular cells express a sulfate dependent
ligand that is sialidase insensitive (46). Additionally, a hepa-
ran-sulfate–based ligand for L-selectin has been detected on
the cell surface of cultured aortic endothelial cells (47). In
vivo, a MECA79-unreactive L-selectin ligand is induced
on venules in a model of dermal inflammation in the
mouse (48). Intravital microscopic studies have revealed
L-selectin ligand activity in mesenteric venules of rat and
rabbit after surgical exteriorization (49, 50) and in venules
of the cremaster muscle of mouse following cytokine treat-
ment (51). Recent studies indicate that this cremaster
ligand activity is due to leukocyte-derived PSGL-1 (52).
Future efforts should be directed at identification of the
class 2 ligand within lymph nodes and the nature of its
posttranslational modifications. Parallel studies (53) indicate
the existence of a class 2 ligand (i.e., MECA79 unreactive)
on medullary venules (order 1 and 2) within lymph nodes
of wild-type mice. Whether this ligand corresponds to the
herein described ligand that is up-regulated in the higher
order venules of HEC-GlcNAc6ST null mice remains to
be determined.
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